Related Experiment Video
Updated: Aug 7, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer
1Division of Tumour Biology, The Netherlands Cancer Institute.
Abstract:
Structural variants of nuclear hormone receptors have been found in tumour tissues. Experimental evidence suggests two ways in which these variants may have oncogenic potential: 1. by suppressing the action of the normal hormone receptor, thereby acting as dominant negative oncogenes; 2. by activating hormone-responsive genes in a hormone-independent manner. These mechanisms may not only contribute to oncogenesis but also to the development of hormone resistance in tumours, e.g. breast and prostate cancer.
Insights
Structural variants of nuclear hormone receptors can promote cancer by interfering with normal receptor function or activating genes independently. These variants also contribute to hormone resistance in cancers like breast and prostate.
Area of Science:
- Molecular biology
- Oncology
- Endocrinology
Background:
- Structural variants of nuclear hormone receptors are identified in tumor tissues.
- These variants are implicated in cancer development and progression.
Purpose of the Study:
- To elucidate the oncogenic potential of nuclear hormone receptor structural variants.
- To understand their role in hormone-independent gene activation and hormone resistance.
Main Methods:
- Review of experimental evidence on nuclear hormone receptor variants.
- Analysis of proposed oncogenic mechanisms.
Main Results:
- Nuclear hormone receptor variants can act as dominant negative oncogenes, suppressing normal receptor function.
- Variants can activate hormone-responsive genes without hormonal signaling.
Conclusions:
- Structural variants of nuclear hormone receptors possess oncogenic potential through dominant-negative effects or hormone-independent gene activation.
- These mechanisms contribute to oncogenesis and the development of hormone resistance in cancers such as breast and prostate cancer.
Related Concept Videos
Intracellular Hormone Receptors
Mitogens and the Cell Cycle
Treatment Resistant Cancers
Signal Transduction: Overview
Typically, signal transduction involves three...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

